We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

146 hedge funds and large institutions have $1.85B invested in Rocket Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 49

1.47% less ownership

Funds ownership: 97.68% → 96.21% (-1.5%)

3% less funds holding

Funds holding: 150 → 146 (-4)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

32% less capital invested

Capital invested by funds: $2.74B → $1.85B (-$888M)

Holders
146
Holders Change
-4
Holders Change %
-2.67%
% of All Funds
2.56%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
12
Increased
55
Reduced
49
Closed
16
Calls
$3.68M
Puts
–
Net Calls
+$3.68M
Net Calls Change
+$566K

Top Buyers

1
MC
Maverick Capital
Texas
+$54.1M
2
RI
RTW Investments
New York
+$29.6M
3
State Street
State Street
Massachusetts
+$21.1M
4
NHAS
Novo Holdings A/S
Denmark
+$19.4M
5
Citadel Advisors
Citadel Advisors
Florida
+$18.2M

Top Sellers

1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$39.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$31.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$17M
4
PA
Perceptive Advisors
New York
-$16.1M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Handelsbanken Fonder
101
Handelsbanken Fonder
Sweden
$287K – – –
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$286K -$4.06M -111,471 -92%
AC
103
Allstate Corporation
Illinois
$285K +$128K +3,527 +59%
Victory Capital Management
104
Victory Capital Management
Texas
$271K -$11.8K -324 -3%
CCA
105
Cobblestone Capital Advisors
New York
$269K -$328K -9,000 -50%
PNC Financial Services Group
106
PNC Financial Services Group
Pennsylvania
$259K +$12.4K +340 +4%
TRCT
107
Tower Research Capital (TRC)
New York
$259K +$198K +5,442 +170%
AWM
108
Avior Wealth Management
Nebraska
$256K – – –
Los Angeles Capital Management
109
Los Angeles Capital Management
California
$245K – – –
Public Employees Retirement Association of Colorado
110
Public Employees Retirement Association of Colorado
Colorado
$245K – – –
US Bancorp
111
US Bancorp
Minnesota
$233K +$69.2K +1,902 +32%
Mitsubishi UFJ Asset Management
112
Mitsubishi UFJ Asset Management
Japan
$227K +$7.68K +211 +3%
OCM
113
Ovata Capital Management
Hong Kong
$224K +$273K +7,500 New
AB
114
Amalgamated Bank
New York
$216K -$9.61K -264 -4%
PHK
115
Point72 Hong Kong
Hong Kong
$198K +$241K +6,630 New
Zurich Cantonal Bank
116
Zurich Cantonal Bank
Switzerland
$140K -$328 -9 -0.2%
VEA
117
Virtus ETF Advisers
New York
$135K -$8.3K -228 -5%
MAM
118
Meeder Asset Management
Ohio
$127K +$126K +3,453 +450%
Amundi
119
Amundi
France
$115K – – –
Royal Bank of Canada
120
Royal Bank of Canada
Ontario, Canada
$102K +$25.1K +689 +25%
AIP
121
Ameritas Investment Partners
Nebraska
$90K – – –
BCV
122
Banque Cantonale Vaudoise
Switzerland
$90K +$109K +3,000 New
HI
123
Harbour Investments
Wisconsin
$67K – – –
Canada Life
124
Canada Life
Manitoba, Canada
$62K – – –
CSS
125
Cubist Systematic Strategies
Connecticut
$54K -$188K -5,162 -74%
3 4
5
6 7

RCKT Hedge Fund Activity: Q3 2021 in Review

146 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2021, worth a combined $1.85B — down 32% from $2.74B a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of RCKT and 12 opened new positions — a net loss of 4 holders — while 49 trimmed existing stakes and 55 added.

The largest buyer was Maverick Capital, adding an estimated $54.1M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $39.8M sold.

  • 146 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2021, down from 150 in Q2 2021.
  • Funds reported $1.85B of Rocket Pharmaceuticals stock for Q3 2021, down 32% quarter-over-quarter.
  • 12 funds opened new Rocket Pharmaceuticals positions in Q3 2021 and 16 closed out, a net change of -4 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2021 was Maverick Capital, an estimated $54.1M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2021 was Loomis, Sayles & Company, an estimated $39.8M sold.

Based on aggregated 13F filings for Q3 2021.